Last updated: February 20, 2024
Sponsor: European Institute of Oncology
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chemotherapy
Breast Cancer
Cancer
Treatment
Omission of surgical treatment
Clinical Study ID
NCT06281210
IEO 2034
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- age> 18 years
- infiltrating breast carcinoma, non-special histotype, triple negative or HER2 +, T1-T2N0
- single lesion
- neo-adjuvant chemotherapy treatment for at least 12 weeks according to clinicalpractice
- conservative surgery proposal
- M0
- tumour bed identified by breast markers placed in pre NACT by radiologist
Exclusion
Exclusion Criteria:
- Bilateral or multicentric tumour
- Presence of microcalcifications visualised on mammography
- Presence of associated DCIS
- Positive history of previous breast cancer
- Positive history of medical or psychiatric conditions preventing adherence to theprotocol
- High risk patient
Study Design
Total Participants: 77
Treatment Group(s): 1
Primary Treatment: Omission of surgical treatment
Phase:
Study Start date:
December 11, 2023
Estimated Completion Date:
December 31, 2028
Study Description
Connect with a study center
Istituto di Candiolo IRCCS
Candiolo, Turin 10060
ItalySite Not Available
European Institute of Oncology
Milan, 20141
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.